Rankings
▼
Calendar
PHIO FY 2018 Earnings — Phio Pharmaceuticals Corp. Revenue & Financial Results | Market Cap Arena
PHIO
Phio Pharmaceuticals Corp.
$13M
FY 2018 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$138,000
+820.0% YoY
Gross Profit
-$4M
-3034.8% margin
Operating Income
-$7M
-5336.2% margin
Net Income
-$7M
-5333.3% margin
EPS (Diluted)
$-6218.35
Cash Flow
Operating Cash Flow
-$8M
Free Cash Flow
-$8M
Stock-Based Comp.
$282,000
Balance Sheet
Total Assets
$15M
Total Liabilities
$2M
Stockholders' Equity
$14M
Cash & Equivalents
$15M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$138,000
$15,000
+820.0%
Gross Profit
-$4M
-$5M
+21.8%
Operating Income
-$7M
-$14M
+47.6%
Net Income
-$7M
-$12M
+40.9%
← Q4 2017
All Quarters
Q1 2018 →